Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer08/07/2018 - 07/31/2023 (PI)
Trustees of Boston University NIH-NCI5R01CA222170-02
DFCI 17-101: Palbociclib After CDK and Endocrine Therapy (PACE): A Randomized Phase II Study…01/02/2020 - 01/01/2023 (PI)
Dana Farber
Improving Cancer Equity: Community-Based Engagement and Interventions01/03/2018 - 02/28/2021 (PI)
Mass General Hosp Kraft Center for Com
Disparities in Breast Cancer Knowledge and Treatment Adherence01/01/2019 - 12/31/2020 (PI)
Dana Farber American Cancer Soc